HilleVax, Inc.
HLVX
$1.86
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 87.06% | 8.15% | 18.83% | -45.75% | -74.16% |
| Total Depreciation and Amortization | -30.69% | 17.96% | 28.94% | 90.19% | 95.84% |
| Total Amortization of Deferred Charges | -- | -100.00% | -100.00% | 25.58% | 26.19% |
| Total Other Non-Cash Items | -90.86% | 329.37% | 68.20% | 371.17% | 608.85% |
| Change in Net Operating Assets | -38.66% | -78.24% | -661.34% | -239.38% | -183.42% |
| Cash from Operations | 61.46% | 15.82% | -3.79% | -32.84% | -106.86% |
| Capital Expenditure | -- | 85.09% | 90.30% | 99.03% | 94.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -63.91% | 128.43% | 275.42% | 95.98% | -- |
| Cash from Investing | -63.48% | 133.77% | 262.44% | 96.14% | -1,831.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -100.00% | 54.52% | 18,727.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -125.43% | -93.97% | 18,727.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.51% | 520.14% | -109.34% | 68.06% | -300.88% |